Could a monthly shot replace daily HIV meds? study halted early
NCT ID NCT02355184
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 27 times
Summary
This study tested whether a monthly injection of an antibody called PRO 140 could keep HIV under control without daily pills. It included 20 adults with HIV who had stable virus levels on standard therapy. The goal was to see how long the virus stayed suppressed after switching to the antibody alone. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CD01-Extension Investigational Site
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.